Detalhe da pesquisa
1.
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
Ann Neurol
; 91(2): 268-281, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878197
2.
Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.
Ann Neurol
; 86(5): 671-682, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486104
3.
Silent progression in disease activity-free relapsing multiple sclerosis.
Ann Neurol
; 85(5): 653-666, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851128
4.
Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.
Mult Scler
; 25(11): 1526-1534, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141729
5.
Harnessing electronic medical records to advance research on multiple sclerosis.
Mult Scler
; 25(3): 408-418, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310490
6.
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
Lancet
; 390(10111): 2481-2489, 2017 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029896
7.
Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS".
Ann Neurol
; 91(5): 735-736, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233827
8.
Long-term evolution of multiple sclerosis disability in the treatment era.
Ann Neurol
; 80(4): 499-510, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27464262
9.
Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
Ann Neurol
; 76(4): 568-80, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25087920
10.
Precision medicine in chronic disease management: The multiple sclerosis BioScreen.
Ann Neurol
; 76(5): 633-42, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25263997
11.
Fulminant Demyelinating Diseases of the Central Nervous System.
Semin Neurol
; 35(6): 656-66, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26595866
12.
Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate.
Acta Neuropathol
; 126(4): 595-601, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23942639
13.
Differential Diagnosis of Tumor-like Brain Lesions.
Neurol Clin Pract
; 13(5): e200182, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664132
14.
Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922025
15.
Remote Observational Research for Multiple Sclerosis: A Natural Experiment.
Neurol Neuroimmunol Neuroinflamm
; 10(2)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585249
16.
Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.
Ann Clin Transl Neurol
; 10(11): 2053-2064, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675826
17.
Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions.
Neurol Neuroimmunol Neuroinflamm
; 7(1)2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719115
18.
Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions.
Neurol Neuroimmunol Neuroinflamm
; 5(6): e505, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30775409
19.
Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.
Neurol Neuroimmunol Neuroinflamm
; 5(3): e453, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564373
20.
Onset of secondary progressive MS after long-term rituximab therapy - a case report.
Ann Clin Transl Neurol
; 4(1): 46-52, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28078314